137 related articles for article (PubMed ID: 26221840)
1. Development of silica-containing redox nanoparticles for medical applications.
Yoshitomi T; Nagasaki Y
Biomater Sci; 2015 Jun; 3(6):810-5. PubMed ID: 26221840
[TBL] [Abstract][Full Text] [Related]
2. Silica-installed redox nanoparticles for novel oral nanotherapeutics - improvement in intestinal delivery with anti-inflammatory effects.
Hossain MA; Yamashita M; Vong LB; Ikeda Y; Nagasaki Y
J Drug Target; 2014 Aug; 22(7):638-47. PubMed ID: 24955616
[TBL] [Abstract][Full Text] [Related]
3. Newly Designed Silica-Containing Redox Nanoparticles for Oral Delivery of Novel TOP2 Catalytic Inhibitor for Treating Colon Cancer.
Vong LB; Kimura S; Nagasaki Y
Adv Healthc Mater; 2017 Oct; 6(20):. PubMed ID: 28736844
[TBL] [Abstract][Full Text] [Related]
4. Sorafenib-loaded silica-containing redox nanoparticles for oral anti-liver fibrosis therapy.
Tran HT; Vong LB; Nishikawa Y; Nagasaki Y
J Control Release; 2022 May; 345():880-891. PubMed ID: 35395328
[TBL] [Abstract][Full Text] [Related]
5. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
Yoshitomi T; Nagasaki Y
Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
[TBL] [Abstract][Full Text] [Related]
6. A silica-based antioxidant nanoparticle for oral delivery of Camptothecin which reduces intestinal side effects while improving drug efficacy for colon cancer treatment.
Nguyen-Trinh QN; Trinh KXT; Trinh NT; Vo VT; Li N; Nagasaki Y; Vong LB
Acta Biomater; 2022 Apr; 143():459-470. PubMed ID: 35235866
[TBL] [Abstract][Full Text] [Related]
7. Improving silymarin oral bioavailability using silica-installed redox nanoparticle to suppress inflammatory bowel disease.
Nguyen TT; Trinh NT; Tran HN; Tran HT; Le PQ; Ngo DN; Tran-Van H; Van Vo T; Vong LB; Nagasaki Y
J Control Release; 2021 Mar; 331():515-524. PubMed ID: 33616078
[TBL] [Abstract][Full Text] [Related]
8. Charged polymer brushes-grafted hollow silica nanoparticles as a novel promising material for simultaneous joint lubrication and treatment.
Liu G; Cai M; Zhou F; Liu W
J Phys Chem B; 2014 May; 118(18):4920-31. PubMed ID: 24735439
[TBL] [Abstract][Full Text] [Related]
9. Fabrication of autofluorescent porous silica nanoparticles for redox-responsive drug release.
Cao N; Zhao Y; Sang B; Wang Z; Cao L; Sun L; Zou X
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():330-6. PubMed ID: 27612720
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of silica-polymer core-shell nanoparticles by reversible addition-fragmentation chain transfer polymerization.
Moraes J; Ohno K; Maschmeyer T; Perrier S
Chem Commun (Camb); 2013 Oct; 49(80):9077-88. PubMed ID: 23999877
[TBL] [Abstract][Full Text] [Related]
11. Mesoporous silica nanoparticles for bioadsorption, enzyme immobilisation, and delivery carriers.
Popat A; Hartono SB; Stahr F; Liu J; Qiao SZ; Qing Max Lu G
Nanoscale; 2011 Jul; 3(7):2801-18. PubMed ID: 21547299
[TBL] [Abstract][Full Text] [Related]
12. Drug-Polymer Electrostatic Complexes as New Structuring Agents for the Formation of Drug-Loaded Ordered Mesoporous Silica.
Molina E; Warnant J; Mathonnat M; Bathfield M; In M; Laurencin D; Jérôme C; Lacroix-Desmazes P; Marcotte N; Gérardin C
Langmuir; 2015 Dec; 31(47):12839-44. PubMed ID: 26566256
[TBL] [Abstract][Full Text] [Related]
13. Silicon-polymer hybrid materials for drug delivery.
McInnes SJ; Voelcker NH
Future Med Chem; 2009 Sep; 1(6):1051-74. PubMed ID: 21425994
[TBL] [Abstract][Full Text] [Related]
14. Preparation of self-assembly silica redox nanoparticles to improve drug encapsulation and suppress the adverse effect of doxorubicin.
Tang MQ; Trinh NT; Vu D; Nguyen TT; Dong HT; Vo TV; Vong LB
ADMET DMPK; 2023; 11(4):551-560. PubMed ID: 37937241
[TBL] [Abstract][Full Text] [Related]
15. Silica-based nanoparticles for biomedical applications.
Bitar A; Ahmad NM; Fessi H; Elaissari A
Drug Discov Today; 2012 Oct; 17(19-20):1147-54. PubMed ID: 22772028
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles end-capped with collagen: redox-responsive nanoreservoirs for targeted drug delivery.
Luo Z; Cai K; Hu Y; Zhao L; Liu P; Duan L; Yang W
Angew Chem Int Ed Engl; 2011 Jan; 50(3):640-3. PubMed ID: 21226142
[No Abstract] [Full Text] [Related]
17. Polymer-Grafted Mesoporous Silica Nanoparticles as Ultrasound-Responsive Drug Carriers.
Paris JL; Cabañas MV; Manzano M; Vallet-Regí M
ACS Nano; 2015 Nov; 9(11):11023-33. PubMed ID: 26456489
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic invertible polymers for adsolubilization on hydrophilic and hydrophobized silica nanoparticles.
Sieburg L; Kohut A; Kislenko V; Voronov A
J Colloid Interface Sci; 2010 Nov; 351(1):116-21. PubMed ID: 20716453
[TBL] [Abstract][Full Text] [Related]
19. PEGylated mesoporous silica as a redox-responsive drug delivery system for loading thiol-containing drugs.
Zhao Q; Wang C; Liu Y; Wang J; Gao Y; Zhang X; Jiang T; Wang S
Int J Pharm; 2014 Dec; 477(1-2):613-22. PubMed ID: 25445534
[TBL] [Abstract][Full Text] [Related]
20. Electrostatic self-assembly of PEG copolymers onto porous silica nanoparticles.
Thierry B; Zimmer L; McNiven S; Finnie K; Barbé C; Griesser HJ
Langmuir; 2008 Aug; 24(15):8143-50. PubMed ID: 18590299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
